135 related articles for article (PubMed ID: 29133367)
21. Roles of regulatory T cells in cancer immunity.
Takeuchi Y; Nishikawa H
Int Immunol; 2016 Aug; 28(8):401-9. PubMed ID: 27160722
[TBL] [Abstract][Full Text] [Related]
22. [Specific suppression in regulatory T cells by Foxp3 siRNA contributes to enhance the in vitro anti-tumor immune response in hepatocellular carcinoma patients].
Zhang HH; Fei R; Xie XW; Wang L; Luo H; Wang XY; Wei L; Chen HS
Beijing Da Xue Xue Bao Yi Xue Ban; 2009 Jun; 41(3):313-8. PubMed ID: 19727215
[TBL] [Abstract][Full Text] [Related]
23. Frequency, suppressive capacity, recruitment and induction mechanisms of regulatory T cells in sinonasal squamous cell carcinoma and nasal inverted papilloma.
Lou H; Fang J; Li P; Zhou W; Wang Y; Fan E; Li Y; Wang H; Liu Z; Xiao L; Wang C; Zhang L
PLoS One; 2015; 10(5):e0126463. PubMed ID: 26020249
[TBL] [Abstract][Full Text] [Related]
24. Epigenetic quantification of tumor-infiltrating T-lymphocytes.
Sehouli J; Loddenkemper C; Cornu T; Schwachula T; Hoffmüller U; Grützkau A; Lohneis P; Dickhaus T; Gröne J; Kruschewski M; Mustea A; Turbachova I; Baron U; Olek S
Epigenetics; 2011 Feb; 6(2):236-46. PubMed ID: 20962591
[TBL] [Abstract][Full Text] [Related]
25. Analysis of CD8+ Treg cells in patients with ovarian cancer: a possible mechanism for immune impairment.
Zhang S; Ke X; Zeng S; Wu M; Lou J; Wu L; Huang P; Huang L; Wang F; Pan S
Cell Mol Immunol; 2015 Sep; 12(5):580-91. PubMed ID: 26166762
[TBL] [Abstract][Full Text] [Related]
26. The PD-1 expressing immune phenotype of T cell exhaustion is prominent in the 'immunoreactive' microenvironment of colorectal carcinoma.
Prall F; Hühns M
Histopathology; 2017 Sep; 71(3):366-374. PubMed ID: 28383777
[TBL] [Abstract][Full Text] [Related]
27. Type I interferon signaling attenuates regulatory T cell function in viral infection and in the tumor microenvironment.
Gangaplara A; Martens C; Dahlstrom E; Metidji A; Gokhale AS; Glass DD; Lopez-Ocasio M; Baur R; Kanakabandi K; Porcella SF; Shevach EM
PLoS Pathog; 2018 Apr; 14(4):e1006985. PubMed ID: 29672594
[TBL] [Abstract][Full Text] [Related]
28. Sorafenib relieves cell-intrinsic and cell-extrinsic inhibitions of effector T cells in tumor microenvironment to augment antitumor immunity.
Chen ML; Yan BS; Lu WC; Chen MH; Yu SL; Yang PC; Cheng AL
Int J Cancer; 2014 Jan; 134(2):319-31. PubMed ID: 23818246
[TBL] [Abstract][Full Text] [Related]
29. T cell subsets and colorectal cancer: discerning the good from the bad.
Scurr M; Gallimore A; Godkin A
Cell Immunol; 2012 Sep; 279(1):21-4. PubMed ID: 23041206
[TBL] [Abstract][Full Text] [Related]
30. Identification of CD8+CD25+Foxp3+ suppressive T cells in colorectal cancer tissue.
Chaput N; Louafi S; Bardier A; Charlotte F; Vaillant JC; Ménégaux F; Rosenzwajg M; Lemoine F; Klatzmann D; Taieb J
Gut; 2009 Apr; 58(4):520-9. PubMed ID: 19022917
[TBL] [Abstract][Full Text] [Related]
31. Immunofluorescence-detected infiltration of CD4+FOXP3+ regulatory T cells is relevant to the prognosis of patients with endometrial cancer.
Yamagami W; Susumu N; Tanaka H; Hirasawa A; Banno K; Suzuki N; Tsuda H; Tsukazaki K; Aoki D
Int J Gynecol Cancer; 2011 Dec; 21(9):1628-34. PubMed ID: 21897268
[TBL] [Abstract][Full Text] [Related]
32. A High RORγT/CD3 Ratio is a Strong Prognostic Factor for Postoperative Survival in Advanced Colorectal Cancer: Analysis of Helper T Cell Lymphocytes (Th1, Th2, Th17 and Regulatory T Cells).
Yoshida N; Kinugasa T; Miyoshi H; Sato K; Yuge K; Ohchi T; Fujino S; Shiraiwa S; Katagiri M; Akagi Y; Ohshima K
Ann Surg Oncol; 2016 Mar; 23(3):919-27. PubMed ID: 26564244
[TBL] [Abstract][Full Text] [Related]
33. Clinical significance of programmed cell death-ligand 1 expression and the immune microenvironment at the invasive front of colorectal cancers with high microsatellite instability.
Korehisa S; Oki E; Iimori M; Nakaji Y; Shimokawa M; Saeki H; Okano S; Oda Y; Maehara Y
Int J Cancer; 2018 Feb; 142(4):822-832. PubMed ID: 29044503
[TBL] [Abstract][Full Text] [Related]
34. Tumor-infiltrating lymphocytes, tumor characteristics, and recurrence in patients with early breast cancer.
Kim ST; Jeong H; Woo OH; Seo JH; Kim A; Lee ES; Shin SW; Kim YH; Kim JS; Park KH
Am J Clin Oncol; 2013 Jun; 36(3):224-31. PubMed ID: 22495453
[TBL] [Abstract][Full Text] [Related]
35. Mismatch repair-deficient colorectal cancer: a model of immunogenic and immune cell-rich tumor despite nonsignificant programmed cell death ligand-1 expression in tumor cells.
Le Flahec G; Badic B; Guibourg B; Doucet L; Bail JP; Marcorelles P; Schick U; Uguen A
Hum Pathol; 2018 Feb; 72():135-143. PubMed ID: 29208565
[TBL] [Abstract][Full Text] [Related]
36. T Regulatory Cells and Priming the Suppressive Tumor Microenvironment.
Paluskievicz CM; Cao X; Abdi R; Zheng P; Liu Y; Bromberg JS
Front Immunol; 2019; 10():2453. PubMed ID: 31681327
[TBL] [Abstract][Full Text] [Related]
37. Characterization of the immunological microenvironment of tumour buds and its impact on prognosis in mismatch repair-proficient and -deficient colorectal cancers.
Zlobec I; Minoo P; Terracciano L; Baker K; Lugli A
Histopathology; 2011 Sep; 59(3):482-95. PubMed ID: 22034888
[TBL] [Abstract][Full Text] [Related]
38. A key role of GARP in the immune suppressive tumor microenvironment.
Hahn SA; Neuhoff A; Landsberg J; Schupp J; Eberts D; Leukel P; Bros M; Weilbaecher M; Schuppan D; Grabbe S; Tueting T; Lennerz V; Sommer C; Jonuleit H; Tuettenberg A
Oncotarget; 2016 Jul; 7(28):42996-43009. PubMed ID: 27248166
[TBL] [Abstract][Full Text] [Related]
39. Foxp3(+) regulatory T cells and natural killer cells distinctly infiltrate primary tumors and draining lymph nodes in pulmonary adenocarcinoma.
Schneider T; Kimpfler S; Warth A; Schnabel PA; Dienemann H; Schadendorf D; Hoffmann H; Umansky V
J Thorac Oncol; 2011 Mar; 6(3):432-8. PubMed ID: 21258248
[TBL] [Abstract][Full Text] [Related]
40. The colorectal cancer immune microenvironment and approach to immunotherapies.
Koi M; Carethers JM
Future Oncol; 2017 Aug; 13(18):1633-1647. PubMed ID: 28829193
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
